New Treatment Target for Fibromyalgia: Inflammation in the Brain
Neuroinflammation in the brain as a therapeutic target
Abnormal neuroinflammation in fibromyalgia and CRPS using [11C]-(R)-PK11195 PET
Abnormal neuroinflammation in fibromyalgia
MAO-A Inhibition by Metaxalone Reverts IL-1β-Induced Inflammatory Phenotype in Microglial Cells
Interesting that Metaxalone has this effect, and it works well for fibromyalgia. More suggestion that there is an autoimmune component.
Brain glial activation in fibromyalgia – A multi-site positron emission tomography investigation
More evidence suggesting autoimmune component in fibromyalgia
Central Role of Dopamine in Fibromyalgia
A review of the evidence that fibromyalgia is associated with a disruption of dopaminergic neurotransmission together with a discussion of its therapeutic implications.